Xiaflex for Treatment of Peyronie's Disease

Eur Urol Focus. 2018 Apr;4(3):302-303. doi: 10.1016/j.euf.2018.08.021. Epub 2018 Sep 10.

Authors

David Shin¹, Tejash Shah², Hossein Sadeghi-Nejad³

Affiliations

¹ Department of Urology, Hackensack University Medical Center, Hackensack, NJ, USA; Divsion of Urology, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: david.shin@hackensackmeridian.org.
² Divsion of Urology, Rutgers New Jersey Medical School, Newark, NJ, USA.
³ Department of Urology, Hackensack University Medical Center, Hackensack, NJ, USA; Divsion of Urology, Rutgers New Jersey Medical School, Newark, NJ, USA.

PMID: 30213657
DOI: 10.1016/j.euf.2018.08.021

Abstract

Xiaflex or collagenase Clostridium histolyticum intralesional injections are safe and effective as first-line treatment for Peyronie's disease.

Copyright © 2018 European Association of Urology. All rights reserved.

Publication types

Comment

MeSH terms

Erectile Dysfunction
Humans
Injections, Intralesional
Male
Microbial Collagenase*
Penile Induration*
Treatment Outcome

Substances

Microbial Collagenase